+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dysmenorrhea Treatment Market - Global Forecast 2025-2030- Product Image
Dysmenorrhea Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Dysmenorrhea Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5896360
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Dysmenorrhea Treatment Market is experiencing significant change, shaped by rising patient demand for tailored care, evolving regulatory policies, and advances in therapeutic technologies. Senior decision-makers are navigating a dynamic environment marked by the integration of precision medicine, digital health tools, and holistic management strategies.

Market Snapshot: Dysmenorrhea Treatment Market Size and Growth Dynamics

The Dysmenorrhea Treatment Market grew from USD 7.80 billion in 2024 to USD 8.51 billion in 2025. It is expected to continue growing at a CAGR of 9.02%, reaching USD 13.10 billion by 2030. This reflects expanding clinical adoption of innovative interventions and the increasing prioritization of menstrual health as a core component of women’s healthcare strategies.

Scope & Segmentation: Defining Market Landscape and Opportunities

  • Treatment Type: Non Pharmacological (Acupuncture Therapy, Dietary Supplements including Herbal Extracts, Omega 3 Supplements, Vitamin Supplements, Exercise Therapy, Heat Therapy), Pharmacological
  • Drug Class: Hormonal Contraceptives, NSAIDs
  • Route of Administration: Injectable, Oral, Topical
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Pharmacy
  • Application: Primary Dysmenorrhea, Secondary Dysmenorrhea
  • End User: Clinics, Home Care, Hospitals, Specialty Centers (including Fitness Centers, Gynecological Clinics)
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, South Africa, UAE), Asia-Pacific (e.g., China, India, Japan, Australia, South Korea, Indonesia, Thailand, Singapore, Vietnam, Taiwan)
  • Competitive Landscape: Analysis includes Bayer AG, Pfizer Inc., Johnson & Johnson Services, Inc., Novartis AG, AbbVie Inc., Merck & Co., Inc., Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd.

Key Takeaways: Strategic Insights for Decision-Makers

  • Innovations in precision medicine and biomarker-driven treatments enable more individualized care pathways, optimizing therapeutic efficacy and patient satisfaction.
  • Digital health technologies, such as mobile apps and wearable devices, are expanding patient monitoring capabilities and fostering remote engagement, especially in underserved areas.
  • Adoption of holistic approaches, including integration of acupuncture, dietary supplementation, and exercise, is increasing, reflecting the broadening scope of patient-centered care.
  • Variations in reimbursement frameworks and regulatory alignment across regions create both obstacles and opportunities, demanding locally tailored market strategies.
  • Collaborative alliances between biotechnology innovators, contract manufacturers, and clinical specialists are accelerating the development and real-world deployment of new therapeutic options.

Tariff Impact: Responding to Shifting Trade Policies

Recent U.S. tariff changes on imported pharmaceutical ingredients and excipients have altered supply chain economics for dysmenorrhea therapies. Companies are adapting by restructuring sourcing models, seeking domestic suppliers, or exploring lower-tariff markets. This environment is driving innovation in delivery systems and procurement, although increased costs pose ongoing challenges for patient access and pricing negotiations with payers.

Methodology & Data Sources

This market analysis employs extensive secondary review of clinical publications, policy documents, and treatment registries, combined with primary interviews with key thought leaders in gynecology, pharmacology, and supply chain management. Data were validated through thematic analysis and benchmarking to industry standards, ensuring robust and reliable insights.

Dysmenorrhea Treatment Market: Why This Report Matters

  • Enables senior leaders to navigate complex market transitions by providing actionable intelligence aligned with evolving clinical and regulatory realities.
  • Supports strategic planning by mapping opportunities across technology adoption, regional expansion, and competitive positioning in the dysmenorrhea care continuum.
  • Empowers organizations to align innovations and partnerships with patient-focused outcomes while addressing operational and economic pressures.

Conclusion

The Dysmenorrhea Treatment Market is evolving rapidly, driven by clinical innovation, digital transformation, and regulatory complexity. Strategic focus on patient needs, robust technology integration, and adaptive supply strategies will be essential for sustained growth and competitiveness.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid growth of digital health platforms offering personalized dysmenorrhea symptom tracking and virtual care coordination
5.2. Increasing investment in novel nonhormonal pharmacotherapies targeting prostaglandin pathways for pain relief in dysmenorrhea patients
5.3. Expansion of women’s health clinics integrating telemedicine services to improve access to dysmenorrhea diagnosis and treatment
5.4. Rising consumer preference for plant-based and nutraceutical supplements for managing menstrual pain with minimal side effects
5.5. Collaborations between biotech startups and academic research centers to develop innovative dysmenorrhea biomarkers for targeted therapies
5.6. Advancements in wearable pain monitoring devices capturing real-time uterine activity data for proactive dysmenorrhea management
5.7. Emergence of AI-driven predictive models to customize dysmenorrhea treatment plans based on patient genetic profiles and medical history
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dysmenorrhea Treatment Market, by Treatment Type
8.1. Introduction
8.2. Non Pharmacological
8.2.1. Acupuncture Therapy
8.2.2. Dietary Supplements
8.2.2.1. Herbal Extracts
8.2.2.2. Omega 3 Supplements
8.2.2.3. Vitamin Supplements
8.2.3. Exercise Therapy
8.2.4. Heat Therapy
8.3. Pharmacological
9. Dysmenorrhea Treatment Market, by Drug Class
9.1. Introduction
9.2. Hormonal Contraceptives
9.3. Nsaids
10. Dysmenorrhea Treatment Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.3. Oral
10.4. Topical
11. Dysmenorrhea Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Pharmacy
12. Dysmenorrhea Treatment Market, by Application
12.1. Introduction
12.2. Primary Dysmenorrhea
12.3. Secondary Dysmenorrhea
13. Dysmenorrhea Treatment Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Home Care
13.4. Hospitals
13.5. Specialty Centers
13.5.1. Fitness Centers
13.5.2. Gynecological Clinics
14. Americas Dysmenorrhea Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Dysmenorrhea Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Dysmenorrhea Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer AG
17.3.2. Pfizer Inc.
17.3.3. Johnson & Johnson Services, Inc.
17.3.4. Novartis AG
17.3.5. AbbVie Inc.
17.3.6. Merck & Co., Inc.
17.3.7. Sanofi S.A.
17.3.8. GlaxoSmithKline plc
17.3.9. Teva Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DYSMENORRHEA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DYSMENORRHEA TREATMENT MARKET: RESEARCHAI
FIGURE 28. DYSMENORRHEA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. DYSMENORRHEA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. DYSMENORRHEA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ACUPUNCTURE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ACUPUNCTURE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OMEGA 3 SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OMEGA 3 SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY VITAMIN SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HEAT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HEAT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HORMONAL CONTRACEPTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HORMONAL CONTRACEPTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY FITNESS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY FITNESS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY GYNECOLOGICAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY GYNECOLOGICAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 117. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 121. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 122. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 123. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 134. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 138. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 139. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 141. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 142. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 143. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 152. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 227. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 230. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 231. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 232. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 233. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 234. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 235. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 244. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 245. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 248. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 249. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 250. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 251. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 252. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 253. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 262. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 281. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 284. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 285. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 286. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 287. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 288. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 289. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 294. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 295. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 298. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 299. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 300. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 301. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 302. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 303. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 304. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 305. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2024 (USD MILLION)
TABLE 316. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CENTERS, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY NON PHARMACOLOGICAL, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES DYSMENORR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Dysmenorrhea Treatment market report include:
  • Bayer AG
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • AbbVie Inc.
  • Merck & Co., Inc.
  • Sanofi S.A.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.51 Billion
Forecasted Market Value ( USD ) by 2030 $ 13.1 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Dysmenorrhea Treatment - Global Strategic Business Report - Product Image

Dysmenorrhea Treatment - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Tianqi Dysmenorrhea Capsules Market - Global Forecast 2025-2030 - Product Image

Tianqi Dysmenorrhea Capsules Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Dysmenorrhea Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Dysmenorrhea Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Dysmenorrhea - Pipeline Insight, 2025 - Product Image

Dysmenorrhea - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Dysmenorrhea Patch Market - Global Forecast 2025-2030 - Product Image

Dysmenorrhea Patch Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From

About the Dysmenorrhea Drug Market

Dysmenorrhea Drug is a type of medication used to treat the pain associated with menstrual cramps. It is a common condition that affects many women of reproductive age. Dysmenorrhea Drug is a part of the Sexual and Reproductive Health Drugs market, which includes medications used to treat a variety of conditions related to sexual and reproductive health. These drugs are used to treat conditions such as infertility, endometriosis, and menopause. They can also be used to prevent pregnancy and to treat sexually transmitted infections. The Dysmenorrhea Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Bayer AG, Pfizer Inc., Merck & Co., Inc., and GlaxoSmithKline plc. Other companies in the market include Allergan plc, Teva Pharmaceutical Industries Ltd., and Mylan N.V. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.